Clinical Trial Detail

NCT ID NCT01526096
Title Stem Cell Transplantation for Patients With Multiple Myeloma
Recruitment Active, not recruiting
Gender
Phase Phase I
Variant Requirements no
Sponsors University of Chicago
Indications

multiple myeloma

Therapies

Basiliximab

Filgrastim

Plerixafor

Melphalan

Age Groups: adult senior

No variant requirements are available.